These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6741865)

  • 41. A phase II clinical trial of diaziquone in the treatment of patients with recurrent endometrial carcinoma. A Gynecologic Oncology Group study.
    Slayton RE; Blessing JA; DiSaia PJ; Phillips G
    Am J Clin Oncol; 1988 Dec; 11(6):612-3. PubMed ID: 3055931
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase I study of aziridinylbenzoquinone (AZQ, NSC 182986) in children with cancer.
    Tan CT; Hancock CH; Mondora A; Hoffman NW
    Cancer Res; 1984 Feb; 44(2):831-5. PubMed ID: 6692381
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aziridinylbenzoquinone (AZQ) in the treatment of recurrent pediatric brain and other malignant solid tumors. A Pediatric Oncology Group phase II study.
    Castleberry RP; Ragab AH; Steuber CP; Kamen B; Toledano S; Starling K; Norris D; Burger P; Krischer JP
    Invest New Drugs; 1990 Nov; 8(4):401-6. PubMed ID: 2084075
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phase I and pharmacokinetic study of trans-N3P3Az2(NHMe)4.
    Mulder NH; Meijers WH; van der Meulen JD; Sleijfer DT; Uges DR; de Vries EG; Postmus PE; van de Grampel JC; Willemse PH
    Cancer Treat Rep; 1987 Feb; 71(2):155-9. PubMed ID: 3026625
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phase II trial of diaziquone in anthracycline-resistant adult soft tissue and bone sarcoma patients: a Southeastern Cancer Study Group Trial.
    Chan C; Bartolucci A; Brenner D; Presant C; Davila E; Carpenter J; Greco FA; Clamon G; Moore J
    Cancer Treat Rep; 1986 Mar; 70(3):427-8. PubMed ID: 3456834
    [No Abstract]   [Full Text] [Related]  

  • 46. Phase II study of aclarubicin and diaziquone in the treatment of advanced small cell bronchogenic carcinoma (EST 4581): an Eastern Cooperative Oncology Group Study.
    Abeloff MD; Finkelstein DM; Chang AY; Camacho FJ; Creech RH; Ettinger DS
    Cancer Treat Rep; 1985 Apr; 69(4):451-2. PubMed ID: 3857972
    [No Abstract]   [Full Text] [Related]  

  • 47. Survival and cell cycle kinetics responses of Chinese hamster ovary cells, and clones of human adenocarcinoma of the stomach and astrocytoma to diaziquone (AZQ) in vitro.
    Barranco SC; Schechter GA; Boerwinkle WR; Howell KA; Rubin NH
    Invest New Drugs; 1983; 1(1):11-9. PubMed ID: 6678853
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aziridinylbenzoquinone in recurrent, progressive glioma of the central nervous system. A Phase II study by the Illinois Cancer Council.
    Haid M; Khandekar JD; Christ M; Johnson CM; Miller SJ; Locker GY; Merrill JM; Reisel H; Hatfield A; Lanzotti V
    Cancer; 1985 Sep; 56(6):1311-5. PubMed ID: 4027870
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phase I clinical evaluation of diaziquone in childhood cancer.
    Ettinger LJ; Siegel SE; Belasco JB; Evans AE; Ruccione KS; Jamin DC; Rohrbaugh TM; Higgins GR
    Cancer Treat Rep; 1985 Mar; 69(3):323-7. PubMed ID: 3856480
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase II evaluation of diaziquone in pancreatic carcinoma: a Southwest Oncology Group Study.
    Tilchen EJ; Fleming T; Mills G; Oishi N; Bonnett JD; Natale RB; Harker G; Coltman CA
    Cancer Treat Rep; 1987 Dec; 71(12):1309-10. PubMed ID: 3690548
    [No Abstract]   [Full Text] [Related]  

  • 51. Continuous-infusion diaziquone in acute myeloid leukemia: a Southeastern Cancer Study Group trial.
    Lyman GH; Vogler WR; Raney M
    Cancer Treat Rep; 1987 Mar; 71(3):309-10. PubMed ID: 3545462
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase I study of aziridinylbenzoquinone (NSC 182986).
    Bedikian AY; Bodey GP; Burgess MA; Freireich EJ
    Cancer Clin Trials; 1981; 4(4):459-63. PubMed ID: 7318128
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent leiomyosarcoma of the uterus. A Gynecologic Oncology Group study.
    Slayton RE; Blessing JA; Look K; Anderson B
    Invest New Drugs; 1991 May; 9(2):207-8. PubMed ID: 1874603
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase II study of continuous-infusion diaziquone in relapsed/refractory acute nonlymphocytic leukemia.
    Schulman P; Davis R; Lee E; Ellerton J; Staszweski H
    Cancer Treat Rep; 1987; 71(7-8):755-7. PubMed ID: 3607786
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Response variability of human brain tumors to AZQ in tissue culture.
    Kornblith PL; Rosa L; Bona JD; Edwards JA; Matuzic N; Hirschfeld A; Hawkins C
    J Neurooncol; 1986; 4(1):49-54. PubMed ID: 3746385
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of patients with recurrent primary brain tumors with AZQ.
    Schold SC; Friedman HS; Bjornsson TD; Falletta JM
    Neurology; 1984 May; 34(5):615-9. PubMed ID: 6538653
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A phase II trial of diaziquone in patients with head and neck cancer.
    Muñiz F; Vélez-García E; Neidhart JA; Bender JF; Becker M; Grillo-Lopez AJ
    Cancer Chemother Pharmacol; 1987; 19(3):265-8. PubMed ID: 3581421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. AZQ therapy in patients with disseminated malignant melanoma.
    Yap BS; Bedikian AY; Burgess MA; Bodey GP
    Am J Clin Oncol; 1982 Dec; 5(6):623-5. PubMed ID: 7165003
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diaziquone and 2,2'-anhydro-arabinosyl-5-fluorocytosine for the treatment of children with relapsed or refractory acute nonlymphoblastic leukemia.
    Meyers PA; Tan CT; Steinherz PG; Redner A
    Cancer; 1989 Dec; 64(12):2416-9. PubMed ID: 2479459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phase I evaluation and pharmacokinetics of aziridinylbenzoquinone using a weekly intravenous schedule.
    Schilcher RB; Young JD; Leichman LP; Haas CD; Baker LH
    Cancer Res; 1983 Aug; 43(8):3907-11. PubMed ID: 6683127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.